Summary
Two antimalarial prophylactic regimens were compared in healthy subjects belonging to the flying personnel of Scandinavian Airlines System. Regimen I: 310 mg chloroquine (CQ) base was given once weekly, starting the week prior to departure to the endemic area, then weekly during presence there and for four weeks after return. Regimen II: a loading dose of 620 mg chloroquine base was given at the latest 48 h prior to departure to the endemic area, followed by 310 mg base weekly throughout the visit. Blood samples were analysed by HPLC for CQ and its major metabolite desethylchloroquine (CQM). Regimen I gave suboptimal whole blood concentrations of CQ and CQM at the end of the first week of treatment. Regimen II gave prophylactic concentrations from the beginning of visit up to 6 weeks after departure from the endemic area.
Both regimens were well tolerated, but Regimen II appeared better accepted by the volunteers due to its shorter duration.
References
World Health Organisation (1984) Advances in malaria chemotherapy. Tech Rep Ser 711 WHO, Geneva
Bergqvist Y, Frisk-Holmberg M (1980) A sensitive method for the determination of chloroquine and its metabolite desethyl-chloroquine in human plasma and urine by high performance liquid chromatography. J Chromatogr 221: 119–120
White NJ (1985) Clinical pharmacokinetics of the malarial drugs. Clin Pharmacokinet 10: 187–215
Rombo L, Bergqvist Y, Hellgren U (1987) Chloroquine and desethyl chloroquine concentrations during regular long term malaria prophylaxic. Bulletin WHO 65: 879–883
Berliner RW, Earle DP, Taggart IV, Zubrod G, Welch WI, Conan NI, Bauman E, Scudder ST, Shannon JA (1948) Studies in the chemotherapy of the human malarias IV. The physiological disposition, antimalarial activity and toxicity of several derivatives of 4-aminoquinolines. J Clin Invest 27: 98–107
Frisk-Holmberg M, Bergqvist Y, Termond E, Domeij-Nyberg B (1984) The single dose kinetics of chloroquine and its major metabolite desetylchloroquine in healthy subjects. Eur J Clin Pharmacol 26: 521–530
References
Frisk-Holmberg M, Bergqvist Y, Termond E, Domeij-Nyberg B (1984) The single dose kinetics of chlorquine and its major metabolite desethylchloroquine in healthy subjects. Eur J Clin Pharmacol 26: 521–530
Gustafsson LL, Rombo L, Alvan G, Björkman A, Lind M, Walter O (1983) On the question of dose dependent chloroquine elimination of a single doral dose. Clin Pharmacol Ther 34: 383–385
Gustafsson LL, Walker O, Alvan G, Beerman B, Estevez F, Gleisner L, Lindström B, Sjoqvist F (1983) Disposition of chloroquine in man after single intravenous and oral doses. Br J Clin Pharmacol 15: 471–479
Adelusi SA, Dawodu AH, Salako LA (1982) Kinetics of the up-take and elimination of chloroquine in children with malaria. Br J Clin Pharmacol 14: 483–487
Rombo L, Bergqvist Y, Hellgren U (1987) Chloroquine and desethylchloroquine concentrations during regular long term malaria prophylaxis. Bull WHO 65: 879–883
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Frisk, M., Gunnert, G., Orme, M. et al. Chloroquine in malaria. Eur J Clin Pharmacol 44, 271–274 (1993). https://doi.org/10.1007/BF00271370
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00271370